$HLTHQ
Cue Health Inc. Stock $hlthq

$hlthq Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000162894522000176 Filed on November 09, 2022

Income Statement

Concept	2022 Q4	2022 Q3
Revenue	$146.8M	$69.59M
YoY Change	-23.75%	-68.89%
Cost Of Revenue	$90.78M	$50.60M
YoY Change	-11.69%	-42.88%
Gross Profit	$55.99M	$18.99M
YoY Change	-37.58%	-85.94%
Gross Profit Margin	38.15%	27.29%
Selling, General & Admin	$38.47M	$43.75M
YoY Change	-13.84%	13.19%
% of Gross Profit	68.7%	230.36%
Research & Development	$56.15M	$42.52M
YoY Change	159.0%	368.29%
% of Gross Profit	100.28%	223.84%
Depreciation & Amortization	$11.95M	$8.300M
YoY Change	85.89%	-27.19%
% of Gross Profit	21.35%	43.7%
Operating Expenses	$94.62M	$86.27M
YoY Change	42.65%	80.73%
Operating Profit	-$38.62M	-$67.41M
YoY Change	-265.19%	-177.15%
Interest Expense	-$232.0K	-$346.0K
YoY Change	307.02%	-80.63%
% of Operating Profit
Other Income/Expense, Net	$2.035M	$409.0K
YoY Change	599.31%	-611.25%
Pretax Income	-$36.82M	-$67.35M
YoY Change	-255.92%	-236.21%
Income Tax	-$5.315M	-$1.047M
% Of Pretax Income
Net Earnings	-$31.51M	-$66.30M
YoY Change	-192.04%	-442.69%
Net Earnings / Revenue	-21.47%	-95.28%
Basic Earnings Per Share		-$0.45
Diluted Earnings Per Share	-$0.21	-$0.45
COMMON SHARES
Basic Shares Outstanding	149.4M shares	148.1M shares
Diluted Shares Outstanding		148.3M shares

Balance Sheet

Concept	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$241.5M	$304.7M
YoY Change	-41.07%	-31.78%
Cash & Equivalents	$241.5M	$304.7M
Short-Term Investments
Other Short-Term Assets	$12.13M	$13.44M
YoY Change	62.96%	543.73%
Inventory	$82.21M	$133.3M
Prepaid Expenses	$15.73M	$44.36M
Receivables	$18.75M	$24.78M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$371.2M	$521.9M
YoY Change	-44.61%	-22.05%
LONG-TERM ASSETS
Property, Plant & Equipment	$274.6M	$279.5M
YoY Change	6.88%	13.09%
Goodwill
YoY Change
Intangibles	$16.87M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.528M	$7.577M
YoY Change	20.11%	438.52%
Total Long-Term Assets	$323.4M	$303.2M
YoY Change	19.77%	20.09%
TOTAL ASSETS
Total Short-Term Assets	$371.2M	$521.9M
Total Long-Term Assets	$323.4M	$303.2M
Total Assets	$694.6M	$825.0M
YoY Change	-26.11%	-10.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.150M	$32.52M
YoY Change	-80.78%	-7.47%
Accrued Expenses	$60.12M	$55.46M
YoY Change	64.05%	83.82%
Deferred Revenue	$1.566M	$84.90M
YoY Change	-98.09%	11.21%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.362M	$2.581M
YoY Change
Total Short-Term Liabilities	$71.20M	$175.5M
YoY Change	-57.35%	-3.4%
LONG-TERM LIABILITIES
Long-Term Debt	$849.0K	$1.268M
YoY Change	-74.04%	-66.99%
Other Long-Term Liabilities	$1.997M	$3.828M
YoY Change	-68.58%	333.03%
Total Long-Term Liabilities	$1.997M	$3.828M
YoY Change	-68.58%	333.03%
TOTAL LIABILITIES
Total Short-Term Liabilities	$71.20M	$175.5M
Total Long-Term Liabilities	$1.997M	$3.828M
Total Liabilities	$118.1M	$235.1M
YoY Change	-49.39%	-12.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$218.1M	-$186.6M
YoY Change	808.07%	220.3%
Common Stock	$1.000K	$1.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$576.5M	$590.0M
YoY Change
Total Liabilities & Shareholders Equity	$694.6M	$825.0M
YoY Change	-26.11%	-10.52%

Cashflow Statement

Concept	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	-$31.51M	-$66.30M
YoY Change	-192.04%	-442.69%
Depreciation, Depletion And Amortization	$11.95M	$8.300M
YoY Change	85.89%	-27.19%
Cash From Operating Activities	-$51.70M	-$39.91M
YoY Change	-684.25%	-304.51%
INVESTING ACTIVITIES
Capital Expenditures	$10.09M	-$18.27M
YoY Change	-126.85%	-5.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.09M	-$18.27M
YoY Change	-73.15%	-5.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.873M	-296.0K
YoY Change	-69.65%	-100.14%
NET CHANGE
Cash From Operating Activities	-51.70M	-39.91M
Cash From Investing Activities	-10.09M	-18.27M
Cash From Financing Activities	-1.873M	-296.0K
Net Change In Cash	-63.66M	-58.47M
YoY Change	82.51%	-128.35%
FREE CASH FLOW
Cash From Operating Activities	-$51.70M	-$39.91M
Capital Expenditures	$10.09M	-$18.27M
Free Cash Flow	-$61.78M	-$21.64M
YoY Change	-233.14%	-155.81%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001628945
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40590
	dei	Entity Registrant Name EntityRegistrantName	Cue Health Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1562193
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4980 Carroll Canyon Rd.
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	149432436	shares
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92121
	dei	City Area Code CityAreaCode	858
	dei	Local Phone Number LocalPhoneNumber	412-8151
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.00001 per share
	dei	Trading Symbol TradingSymbol	HLTH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304654000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	409873000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1334000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	13837000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24779000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	104589000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	133309000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	88388000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44355000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45889000	usd
CY2022Q3	us-gaap	Other Assets Current OtherAssetsCurrent	13441000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	7446000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	521872000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	670022000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	194259000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	177456000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85284000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79474000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16044000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7673000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7577000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5435000	usd
CY2022Q3	us-gaap	Assets Assets	825036000	usd
CY2021Q4	us-gaap	Assets Assets	940060000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	32521000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	37208000	usd
CY2022Q3	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	47105000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	29498000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	8297000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	84899000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	82165000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8356000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7147000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2581000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2621000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	175462000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	166936000	usd
CY2022Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10283000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10283000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44235000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46464000	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1268000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3271000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3828000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6356000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	235076000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	233310000	usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	149177691	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	149177691	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	146402991	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	146402991	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	776527000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	730767000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-186568000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24018000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	589960000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	706750000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	825036000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	940060000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	69589000	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	223679000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	336699000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	425601000	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	18129000	usd
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5572000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	69268000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	7531000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	42516000	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9079000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	115303000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21150000	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25625000	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33084000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	77946000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	56336000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	137000	usd
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	0	usd
	us-gaap	Restructuring Charges RestructuringCharges	2020000	usd
	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	137002000	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	136304000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	503727000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	258763000	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-67413000	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	87375000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-167028000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	166838000	usd
CY2022Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-346000	usd
CY2021Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-1786000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-413000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-9752000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-243000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53000	usd
CY2022Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
CY2021Q3	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-36306000	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	usd
	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-59560000	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1998000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	409000	usd
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-80000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	458000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-67350000	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	49446000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-166983000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	95562000	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1047000	usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30098000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4433000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43374000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-66303000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	19348000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-162550000	usd
	us-gaap	Net Income Loss NetIncomeLoss	52188000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	148285721	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31554720	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147443196	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22997311	shares
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	148285721	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39304978	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147443196	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30747569	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	640373000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1468000	usd
CY2022Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1268000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15690000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-66303000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	589960000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-61332000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	177691000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	297792000	usd
CY2021Q3	hlth	Non Cash And Payment Of Stock Issuance Costs NonCashAndPaymentOfStockIssuanceCosts	24000000.0	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	205293000	usd
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	159000	usd
CY2021Q3	hlth	Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions	46000	usd
CY2021Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4586000	usd
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19967000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	19348000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	654378000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	706750000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1980000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4735000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	48515000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-162550000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	589960000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-101400000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	177691000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	417000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	297792000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	1239000	usd
	hlth	Non Cash And Payment Of Stock Issuance Costs NonCashAndPaymentOfStockIssuanceCosts	24000000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	205293000	usd
	hlth	Stock Issued During Period Value Common Stock Warrants Exercised StockIssuedDuringPeriodValueCommonStockWarrantsExercised	77000	usd
	hlth	Adjustments To Additional Paid In Capital Vesting Of Early Exercised Stock Options AdjustmentsToAdditionalPaidInCapitalVestingOfEarlyExercisedStockOptions	109000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4586000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25558000	usd
	us-gaap	Net Income Loss NetIncomeLoss	52188000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	654378000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-162550000	usd
	us-gaap	Net Income Loss NetIncomeLoss	52188000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	32989000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	26079000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53000	usd
	hlth	Change In Fair Value Of Convertible Notes ChangeInFairValueOfConvertibleNotes	0	usd
	hlth	Change In Fair Value Of Convertible Notes ChangeInFairValueOfConvertibleNotes	-59560000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	48515000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	25558000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1998000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6215000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	3462000	usd
	hlth	Convertible Notes Issuance Costs ConvertibleNotesIssuanceCosts	0	usd
	hlth	Convertible Notes Issuance Costs ConvertibleNotesIssuanceCosts	6000000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3478000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	883000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	137000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	154000	usd
	hlth	Share Based Payment Arrangement Noncash Expense Issuance Of Fully Vested Warrant To Vendor ShareBasedPaymentArrangementNoncashExpenseIssuanceOfFullyVestedWarrantToVendor	0	usd
	hlth	Share Based Payment Arrangement Noncash Expense Issuance Of Fully Vested Warrant To Vendor ShareBasedPaymentArrangementNoncashExpenseIssuanceOfFullyVestedWarrantToVendor	1239000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	319000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1857000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	33191000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	0	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	12263000	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	0	usd
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-79810000	usd
	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	86022000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	78112000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	33897000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7151000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25487000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1912000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3871000	usd
	hlth	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	9364000	usd
	hlth	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	0	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1138000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5270000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-11331000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	37365000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2734000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-75529000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-3632000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-15052000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60219000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-18298000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	43179000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	74637000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9767000	usd
	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	3524000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-52946000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-78161000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	235480000	usd
	hlth	Payments Of Redeemable Convertible Preferred Stock Issuance Costs PaymentsOfRedeemableConvertiblePreferredStockIssuanceCosts	0	usd
	hlth	Payments Of Redeemable Convertible Preferred Stock Issuance Costs PaymentsOfRedeemableConvertiblePreferredStockIssuanceCosts	-89000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	6000000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1980000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	418000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	77000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	230000000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	22062000	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	82250000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4735000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	4586000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	977000	usd
	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	0	usd
	hlth	Payments Of Financing Costs Excluding Convertible Notes Debt Issuance Costs PaymentsOfFinancingCostsExcludingConvertibleNotesDebtIssuanceCosts	599000	usd
	hlth	Payments Of Financing Costs Excluding Convertible Notes Debt Issuance Costs PaymentsOfFinancingCostsExcludingConvertibleNotesDebtIssuanceCosts	781000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	87684000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2180000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1408000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4557000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	425793000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-117722000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	329334000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	423710000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	129255000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305988000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	458589000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	304654000	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	446589000	usd
CY2022Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1334000	usd
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	12000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	305988000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	458589000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5100000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	760000	usd
	hlth	Early Exercised Stock Options Liability EarlyExercisedStockOptionsLiability	0	usd
	hlth	Early Exercised Stock Options Liability EarlyExercisedStockOptionsLiability	109000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2611000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	47611000	usd
	hlth	Prepaid Rent Reclassified To Right Of Use Assets PrepaidRentReclassifiedToRightOfUseAssets	50000	usd
	hlth	Prepaid Rent Reclassified To Right Of Use Assets PrepaidRentReclassifiedToRightOfUseAssets	15966000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4313000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	18708000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	176322000	usd
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	297792000	usd
	hlth	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	0	usd
	hlth	Stock Issuance Costs Incurred But Not Yet Paid StockIssuanceCostsIncurredButNotYetPaid	2644000	usd
	hlth	Software Development Costs Incurred But Not Yet Paid SoftwareDevelopmentCostsIncurredButNotYetPaid	995000	usd
	hlth	Software Development Costs Incurred But Not Yet Paid SoftwareDevelopmentCostsIncurredButNotYetPaid	0	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the accompanying unaudited interim condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities as of the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could materially differ from those estimates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to revenue recognition, net accounts receivable, equity-based compensation expense, product warranty reserve, the usage and recoverability of its inventories and long-lived assets and net deferred tax assets (and related valuation allowance). The </span></div>Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	2600000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	45500000	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	2600000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	45500000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	33200000	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	12300000	usd
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	400000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1100000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	92448000	usd
	hlth	Contract With Customer Liability Unearned Revenue From Cash Received During The Period ContractWithCustomerLiabilityUnearnedRevenueFromCashReceivedDuringThePeriod	2734000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	95182000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2000000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	300000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	45500000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	75594000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	46273000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	20925000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10920000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	74445000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	33863000	usd
CY2022Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	37655000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2668000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	133309000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	88388000	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	2600000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	45500000	usd
CY2022Q3	us-gaap	Inventory Write Down InventoryWriteDown	2600000	usd
	hlth	Inventory Reserve Period Charge InventoryReservePeriodCharge	33200000	usd
	hlth	Product Warranty Reserve ProductWarrantyReserve	12300000	usd
CY2022Q3	hlth	Prepaid Expense Excluding Prepaid Inventory Current PrepaidExpenseExcludingPrepaidInventoryCurrent	31561000	usd
CY2021Q4	hlth	Prepaid Expense Excluding Prepaid Inventory Current PrepaidExpenseExcludingPrepaidInventoryCurrent	30153000	usd
CY2022Q3	hlth	Prepaid Inventory Current PrepaidInventoryCurrent	12794000	usd
CY2021Q4	hlth	Prepaid Inventory Current PrepaidInventoryCurrent	15736000	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44355000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	45889000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	266582000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	219125000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	72323000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	41669000	usd
CY2022Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	194259000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	177456000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	8300000	usd
CY2021Q3	us-gaap	Depreciation Depreciation	11400000	usd
	us-gaap	Depreciation Depreciation	28600000	usd
	us-gaap	Depreciation Depreciation	24200000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	16037000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	5638000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	4459000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2067000	usd
CY2022Q3	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	11578000	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	3571000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	16044000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7673000	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	200000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1900000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	85284000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	79474000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	7723000	usd
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9821000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8356000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7147000	usd
CY2022Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2581000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2621000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44235000	usd
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46464000	usd
CY2022Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1268000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3271000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	3192000	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	2398000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	8749000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	5365000	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	819000	usd
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	509000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2098000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	1215000	usd
CY2022Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	43000	usd
CY2021Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	54000	usd
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	137000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	154000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	4054000	usd
CY2021Q3	us-gaap	Lease Cost LeaseCost	2961000	usd
	us-gaap	Lease Cost LeaseCost	10984000	usd
	us-gaap	Lease Cost LeaseCost	6734000	usd
CY2022Q3	hlth	Accrued Liabilities Purchases Current AccruedLiabilitiesPurchasesCurrent	4535000	usd
CY2021Q4	hlth	Accrued Liabilities Purchases Current AccruedLiabilitiesPurchasesCurrent	285000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22041000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13693000	usd
CY2022Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3154000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6371000	usd
CY2022Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6484000	usd
CY2021Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4284000	usd
CY2022Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	10891000	usd
CY2021Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	4865000	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	47105000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	29498000	usd
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	297800000	usd
CY2021Q3	hlth	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	550000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9163160	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.13
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y4M24D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1158772	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.52
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	188209	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	12.46
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	80406	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	14.62
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7735773	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	5.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M29D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	5823768	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.71
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	7735773	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	5.55
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P6Y3M29D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-66303000	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	19348000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-162550000	usd
	us-gaap	Net Income Loss NetIncomeLoss	52188000	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	14926000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	43670000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-66303000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4422000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-162550000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	8518000	usd
CY2022Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
CY2021Q3	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	701000	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	0	usd
	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Diluted UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted	2142000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-66303000	usd
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	5123000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-162550000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	10660000	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	148285721	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31554720	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	147443196	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22997311	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	148285721	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39304978	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	147443196	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30747569	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.37
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.10
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.35
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26647055	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12515387	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	26647055	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12515387	shares
CY2022Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.016
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.027
CY2021Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.609
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.454
	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1700000	usd
CY2022Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	300000	usd
	hlth	Standard Product Warranty Term StandardProductWarrantyTerm	P12M
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4865000	usd
	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	7080000	usd
	hlth	Standard Product Warranty Accrual Increase Due To Inventory Charge StandardProductWarrantyAccrualIncreaseDueToInventoryCharge	12263000	usd
	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	13317000	usd
CY2022Q3	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	10891000	usd
CY2022Q3	us-gaap	Restructuring Charges RestructuringCharges	100000	usd
	us-gaap	Restructuring Charges RestructuringCharges	2000000	usd
CY2021Q4	hlth	Number Of Letters Of Credit In Effect NumberOfLettersOfCreditInEffect	1	letter_of_credit
CY2021Q4	hlth	Number Of Letters Of Credit In Effect NumberOfLettersOfCreditInEffect	1	letter_of_credit
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	800000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001628945-22-000176-index-headers.html	Edgar Link	pending
0001628945-22-000176-index.html	Edgar Link	pending
0001628945-22-000176.txt	Edgar Link	pending
0001628945-22-000176-xbrl.zip	Edgar Link	pending
exhibit31109302210-q.htm	Edgar Link	pending
exhibit31209302210-q.htm	Edgar Link	pending
exhibit32109302210-q.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hlth-20220930.htm	Edgar Link	pending
hlth-20220930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
hlth-20220930_def.xml	Edgar Link	unprocessable
hlth-20220930_pre.xml	Edgar Link	unprocessable
hlth-20220930_lab.xml	Edgar Link	unprocessable
hlth-20220930_cal.xml	Edgar Link	unprocessable
hlth-20220930_htm.xml	Edgar Link	completed
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HLTHQ
Cue Health Inc. Stock $hlthq

2022 Q4 Form 10-Q Financial Statement

#000162894522000176 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLTHQ Cue Health Inc. Stock $hlthq

2022 Q4 Form 10-Q Financial Statement

#000162894522000176 Filed on November 09, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HLTHQ
Cue Health Inc. Stock $hlthq